Page 193 - Fluid, Electrolyte, and Acid-Base Disorders in Small Animal Practice

Disorders of Calcium: Hypercalcemia and Hypocalcemia 183

gland tumors in dogs. Part III: Clinical trials and results in 1,25-dihydroxyvitamin D3 leads to early effects within
three dogs. J Am Anim Hosp Assoc 1988;24:673–8. the central nervous system. Acta Neuropathol (Berl)
186. Fitzpatrick LA, Brandi ML, Aurbach GD. Control of 2003;105:438–48.
PTH secretion is mediated through calcium channels 206. Garlock SM, Matz ME, Shell LG. Vitamin D3 rodenticide
and is blocked by pertussis toxin treatment of parathyroid toxicity in a dog. J Am Anim Hosp Assoc
cells. Biochem Biophys Res Commun 1986;138:960–5. 1991;27:356–60.
187. Flanders JA, Harvey HJ, Erb HN. Feline thyroidectomy: 207. Garrett IR. Bone destruction in cancer. Semin Oncol
a comparison of postoperative hypocalcemia associated 1993;20(Suppl. 2):4–9.
with three different surgical techniques. Vet Surg 208. Gaschen F, Gaschen L, Seiler G, et al. Lethal peracute
1987;16:362–6. rhabdomyolysis associated with stress and general anes-
188. Flanders JA, Neth S, Erb HN, et al. Functional analysis of thesia in three dystrophin-deficient cats. Vet Pathol
ectopic parathyroid activity in cats. Am J Vet Res 1998;35:117–23.
1991;52:1336–40. 209. Gascon-Barre M. The vitamin D 25-hydroxylase. In:
189. Flanders JA, Scarlett JM, Blue JT, et al. Adjustment of Feldman D, editor. Vitamin D. New York: Academic
total serum calcium concentration for binding to albumin Press; 1997. p. 41–56.
and protein in cats: 291 cases (1986-1987). J Am Vet Med 210. Geisen V, Weber K, Hartmann K. Vitamin D-dependent
Assoc 1989;194:1609–11. hereditary rickets type I in a cat. J Vet Intern Med
190. Flanders JA. Surgical therapy of the thyroid. Vet Clin 2009;23(1):196–9.
North Am Small Anim Pract 1994;24:607–21. 211. Gertz BJ, Holland SD, Kline WF, et al. Studies of the oral
191. Fleisch H. Bisphosphonates: pharmacology and use in the bioavailability of alendronate. Clin Pharmacol Ther
treatment of tumour-induced hypercalcaemic and meta- 1995;58:288–98.
static bone disease. Drugs 1991;42:919–44. 212. Ghazarian JG. The renal mitochondrial hydroxylases of
192. Fleisch H. Mechanisms of action of the bisphosphonates. the vitamin D3 endocrine complex: how are they
Medicina (B Aires) 1997;57(Suppl. 1):65–75. regulated at the molecular level? J Bone Miner Res
193. Foley RN. Phosphorus comes of age as a cardiovascular 1990;5:897–903.
risk factor. Arch Intern Med 2007;167:873–4. 213. Goldstein RE, Long C, Swift NC, et al. Percutaneous eth-
194. Fooshee SK, Forrester SD. Hypercalcemia secondary to anol injection for treatment of unilateral hyperplastic thy-
cholecalciferol rodenticide toxicosis in two dogs. J Am roid nodules in cats. J Am Vet Med Assoc
Vet Med Assoc 1990;196:1265–8. 2001;218:1298–302.
195. Forbes S, Nelson RW, Guptill L. Primary hypoparathy- 214. Goodman WG, Belin T, Gales B, et al. Calcium-regulated
roidism in a cat. J Am Vet Med Assoc 1990;196:1285–7. parathyroid hormone release in patients with mild or
196. Fournel-Fleury C, Ponce F, Felman P, et al. Canine T-cell advanced secondary hyperparathyroidism. Kidney Int
lymphomas: a morphological, immunological, and clinical 1995;48:1553–8.
study of 46 new cases. Vet Pathol 2002;39:92–109. 215. Goodman WG, Veldhuis JD, Belin TR, et al. Calcium-
197. Fradkin JM, Braniecki AM, Craig TM, et al. Elevated sensing by parathyroid glands in secondary hyperparathy-
parathyroid hormone-related protein and hypercalcemia roidism. J Clin Endocrinol Metab 1998;83:2765–72.
in two dogs with schistosomiasis. J Am Anim Hosp Assoc 216. Goodman WG. New assays for parathyroid hormone
2001;37:349–55. (PTH) and the relevance of PTH fragments in renal
198. Franceschini N, Joy MS, Kshirsagar A. Cinacalcet HCl: a failure. Kidney Int Suppl 2003;85:S120–4.
calcimimetic agent for the management of primary and 217. Goodman WG. Recent developments in the management
secondary hyperparathyroidism. Expert Opin Investig of secondary hyperparathyroidism. Kidney Int
Drugs 2003;12:1413–21. 2001;59:1187–201.
199. Fraser D, Jones G, Kooh SW, et al. Calcium and phosphate 218. GoslingP.Analyticalreviewsinclinicalbiochemistry:calcium
metabolism. In: Philadelphia: WB Saunders; 1986. measurement. Ann Clin Biochem 1986;23:t146–56.
p. 1317–1372. 219. Goswami R, Brown EM, Kochupillai N, et al. Prevalence
200. Fraser D, Jones G, Kooh SW. Calcium and phosphate of calcium sensing receptor autoantibodies in patients
metabolism. In: Tietz NW, editor. Fundamentals of clini- with sporadic idiopathic hypoparathyroidism. Eur J
cal chemistry. Philadelphia: WB Saunders; 1987. Endocrinol 2004;150:9–18.
p. 705–728. 220. Gouget B, Gourmelin Y, Blanchet F, et al. Ca 2þ measure-
201. Frolik CA, Black EC, Cain RL, et al. Anabolic and cata- ment with ion selective electrodes: the French coordi-
bolic bone effects of human parathyroid hormone (1- nated evaluation of seven analyzers, for a better clinical
34) are predicted by duration of hormone exposure. Bone relevance and acceptance. Ann Biol Clin (Paris)
2003;33:372–9. 1988;46:419–34.
202. Fukagawa M, Kitaoka M, Kurokawa K. Renal failure and 221. Gow AG, Gow DJ, Bell R, Simpson JW, Chandler ML,
hyperparathyroidism. In: Feldman D, editor. Vitamin D. Evans H, et al. Calcium metabolism in eight dogs with
New York: Academic Press; 1997. p. 1227–1239. hypoadrenocorticism. J Small Anim Pract 2009;50
203. Galitzer H, Ben-Dov I, Lavi-Moshayoff V, et al. Fibro- (8):426–30.
blast growth factor 23 acts on the parathyroid to decrease 222. Grant WB, Garland CF. Evidence supporting the role of
parathyroid hormone secretion. Curr Op Nephrol Hyper vitamin D in reducing the risk of cancer. J Intern Med
2008;17:363–7. 2002;252:178–9, author reply 179–180.
204. Gao P, Scheibel S, D’Amour P, et al. Development of a 223. Graves TK. Complications of treatment and concurrent
novel immunoradiometric assay exclusively for biologi- illness associated with hyperthyroidism in cats. In:
cally active whole parathyroid hormone 1-84: implications Bonagura JD, editor. Kirk’s current veterinary therapy
for improvement of accurate assessment of parathyroid XII: small animal practice. Philadelphia: WB Saunders;
function. J Bone Miner Res 2001;16:605–14. 1995. p. 369–372.
205. Garcion E, Sindji L, Nataf S, et al. Treatment of 224. Green MD. Oral bisphosphonates and malignancy. Med J
experimental autoimmune encephalomyelitis in rat by Aust 1997;167:211–2.